Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure (Q44620764)
Jump to navigation
Jump to search
scientific article published on 17 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure |
scientific article published on 17 September 2008 |
Statements
1 reference
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure (English)
1 reference
1 reference
S Vincent Rajkumar
1 reference
Robert D Knight
1 reference
Michael Wang
1 reference
Christine Chen
1 reference
M Teresa Cibeira
1 reference
Michel Attal
1 reference
Andrew Spencer
1 reference
Zhinuan Yu
1 reference
Marta Olesnyckyj
1 reference
Jerome B Zeldis
1 reference
Donna M Weber
1 reference
17 September 2008
1 reference
Identifiers
1 reference